Verve Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a Q&A table for Verve Therapeutics Inc. Full ESG analysis of Verve Therapeutics Inc can be accessed by registering for free. The analysis of Verve Therapeutics Inc incorporates data points from across the internet and also from available filings by Verve Therapeutics Inc.
Verve Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 1.3, social score of 2.3 and governance score of 4.0.
2.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1481 | Tissue Regenix Group PLC | 2.6 | Medium |
| 1481 | Twist Bioscience Corp | 2.6 | Medium |
| 1499 | Verve Therapeutics Inc | 2.5 | Medium |
| 1499 | Akeso Inc | 2.5 | Medium |
| 1499 | Allergan plc | 2.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Verve Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Verve Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Verve Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Verve Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Verve Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Verve Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Verve Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Verve Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Verve Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Verve Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Verve Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Verve Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Verve Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Verve Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Verve Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Verve Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Verve Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Verve Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.